cadmium has been researched along with Leukemia, Myeloid, Acute in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wan, XM; Zheng, C; Zhou, XL | 1 |
| Angel, CR; Bishop, MR; Iversen, PL; Mata, JE; Swanson, SA; Tarantolo, SR | 1 |
1 trial(s) available for cadmium and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Evidence of enhanced iron excretion during systemic phosphorothioate oligodeoxynucleotide treatment.
Topics: Cadmium; Chelating Agents; Copper; Dose-Response Relationship, Drug; Erythrocyte Count; Humans; Infusions, Intravenous; Iron; Iron Chelating Agents; Leukemia, Myeloid, Acute; Male; Metabolic Clearance Rate; Middle Aged; Myelodysplastic Syndromes; Oligodeoxyribonucleotides, Antisense; RNA, Messenger; Spectrophotometry, Atomic; Thionucleotides; Tumor Suppressor Protein p53; Zinc | 2000 |
1 other study(ies) available for cadmium and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Puerarin prevents cadmium-induced mitochondrial fission in AML-12 cells via Sirt1-dependent pathway.
Topics: Animals; Cadmium; Leukemia, Myeloid, Acute; Mice; Mitochondrial Dynamics; Sirtuin 1 | 2022 |